<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <title>Johnson & Johnson Says Potential Non-Small Cell Lung Cancer Treatment Improves Overall Survival</title>
</head>
<body>
  <a href="../../index.html">← Back to home</a>
  <h1>Johnson & Johnson Says Potential Non-Small Cell Lung Cancer Treatment Improves Overall Survival</h1>
  <ul>
<li>Johnson &amp; Johnson Says Potential Non-Small Cell Lung Cancer Treatment Improves Overall Survival Johnson &amp; Johnson (JNJ) said Sunday results of a phase 3 study of Rybrevant plus Lazcluze as a poten Upgrade to read this MT</li>
<li>A Silver or Gold subscription plan is required to access premium news articles.</li>
</ul>
<p><a href="https://finance.yahoo.com/news/johnson-johnson-says-potential-non-074936040.html">Source</a> · 2025-09-08T07:49:36+00:00</p>
</body>
</html>